JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M307451200 on July 28, 2003

J. Biol. Chem., Vol. 278, Issue 41, 40373-40384, October 10, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/41/40373    most recent
M307451200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umigai, N.
Right arrow Articles by Uozumi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umigai, N.
Right arrow Articles by Uozumi, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Topogenesis of Two Transmembrane Type K+ Channels, Kir 2.1 and KcsA*

Naofumi Umigai {ddagger}, Yoko Sato {ddagger} §, Akifumi Mizutani ¶, Toshihiko Utsumi ||, Masao Sakaguchi ** and Nobuyuki Uozumi {ddagger} ¶ {ddagger}{ddagger}

From the {ddagger}Graduate School of Bioagricultural Sciences and the Bioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, the ||Faculty of Agriculture, Yamaguchi University, Yamaguchi 753-8515, and the **Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582, Japan

Received for publication, July 11, 2003 , and in revised form, July 24, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Potassium channels, which control the passage of K+ across cell membranes, have two transmembrane segments, M1 and M2, separated by a hydrophobic P region containing a highly conserved signature sequence. Here we analyzed the membrane topogenesis characteristics of the M1, M2, and P regions in two animal and bacterial two-transmembrane segment-type K+ channels, Kir 2.1 and KcsA, using an in vitro translation and translocation system. In contrast to the equivalent transmembrane segment, S5, in the voltage-dependent K+ channel, KAT1, the M1 segment in KcsA, was found to have a strong type II signal-anchor function, which favors the Ncyt/Cexo topology. The N-terminal cytoplasmic region was required for efficient, correctly orientated integration of M1 in Kir 2.1. Analysis of N-terminal modification by in vitro metabolic labeling showed that the N terminus in Kir 2.1 was acetylated. The hydrophobic P region showed no topogenic function, allowing it to form a loop, but not a transmembrane structure in the membrane; this region was transiently exposed in the endoplasmic reticulum lumen during the membrane integration process. M2 was found to possess a stop-transfer function and a type I signal-anchor function, enabling it to span the membrane. The C-terminal cytoplasmic region in KcsA was found to affect the efficiency with which the M2 achieved their final structure. Comparative topogenesis studies of Kir 2.1 and KcsA allowed quantification of the relative contributions of each segment and the cytoplasmic regions to the membrane topology of these two proteins. The membrane topogenesis of the pore-forming structure is discussed using results for Kir 2.1, KcsA, and KAT1.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Membrane insertion of the polypeptide and the formation of the correct functional channel structure occurs in the ER1 membrane (1). Each transmembrane segment must take up the correct orientation of the two possible options, Nexo/Ccyt or Ncyt/Cexo. The topogenic function of transmembrane segments of polytopic membrane proteins is determined by the presence of type I (SA-I) and type II (SA-II) signal-anchor sequences. SA-I transmembrane segments assume the Nexo/Ccyt orientation, whereas SA-II transmembrane segments assume the Ncyt/Cexo orientation. Studies on the topogenesis of eukaryotic polytopic membrane proteins have shown that a series of hydrophobic domains can be sequentially integrated via the translocon into the ER membrane (2-4). In this case, hydrophobic regions after the Ncyt/Cexo-orientated transmembrane segment remain within the membrane if they act as the "stop-transfer" function.

The K+ channel ion conduction pore has two transmembrane segments (M1 and M2), a hydrophobic region responsible for K+ selectivity (P region), and N- and C-terminal cytoplasmic domains (Fig. 1). Recent high resolution structural data for the "membrane-pore-membrane" structure of the bacterial K+ channels, KcsA, MthK, KvAP, and KirBac 1.1, have revealed that the P region forms a loop structure, N-terminal to C-terminal, consisting of a helix, a turn, and a random coil (5-9). The overall structure of the pore-forming region is highly conserved not only in Na+ and Ca2+ channels but also in plant and bacterial Na+/K+ transporters (HKT, Ktr, and Trk) (10-14).



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 1.
Transmembrane segments of two-transmembrane-type K+ channels, Kir 2.1 and KcsA. Upper section, schematic diagram of the suggested insertion of the protein in the ER membrane. The pore helix is located in the first half of the P region and the K+-selective filter (shown boxed) in the second half. Lower section, the DNA fragments encoding M1 (underlined by a black line), the P region (dotted line), or M2 (wavy line) were used in the constructs for the analysis of topogenic function shown in Figs. 2, 3, and 5.

 



View larger version (36K):
[in this window]
[in a new window]
 
FIG. 2.
Nexo/Ccyt (SA-I) or Ncyt/Cexo (SA-II) topogenic function of each transmembrane segment. A, the model protein used to assess the orientation of the translocation initiation function. Top section, the segments M1, P, or M2 were inserted between the glycosylation loop of band 3 protein and mature PL. Middle section, the N-terminal cytoplasmic region of Kir 2.1 containing K34N and M1 of Kir 2.1 were fused to PL. The PL domain is 200 amino acids long. Bottom section, if the segment shows SA-I function (Nexo/Ccyt orientation), the protein is glycosylated, and a large part of the fusion protein is hydrolyzed by proteinase K, and if it shows SA-II function (Ncyt/Cexo orientation), the protein is not glycosylated and the PL domain is protected. B and C, left panels, autoradiographs of SDS-PAGE gels for the Kir 2.1 (B) and KcsA (C) constructs. The proteins were expressed in the absence (-) or presence (+) of RM; a sample of the latter was also treated with proteinase K (PK+). The glycosylated band is indicated by a dot, and the proteinase K-resistant band is indicated by an arrowhead. Right panel, efficiency of topogenic orientation of each segment. The translocation initiation efficiency was calculated using the equations proposed by Ota et al. (21). The glycosylated (b) and nonglycosylated (ng) form and the proteinase K-resistant form (a) were quantified by image analysis and the results compensated for Met content. The SA-I or SA-II functions were then calculated as SA-I efficiency = 100 x (b)/((b) + (ng)) and SA-II efficiency = 100 x (a)/k x ((b) + (ng)), where k is the efficiency of the membrane in protecting translocated mature PL from proteinase K degradation calculated using the equation k = (intensity of mature PL after proteinase K treatment)/(intensity of mature PL before proteinase K treatment) (data not shown). Compensation was made for the number of methionines in each protected form.

 


View larger version (31K):
[in this window]
[in a new window]
 
FIG. 3.
Translocation initiation function of each segment of Kir 2.1 and KcsA. A, constructs used to assess translation initiation (reinitiation) function. The N terminus of the inserted segment was forced to face the cytoplasmic space by placing it after the SA-I (Nexo/Ccyt) of the H1 segment of the E. coli leader peptidase (H1) which precedes the N-glycosylation site domain. The model protein contained a PL domain fused to the C terminus of the inserted segment, M1, P. or M2. B and C, left, autoradiographs of SDS-PAGE gels of the Kir 2.1 (B) and KcsA (C) constructs. The presence of the glycosylated form (dots) verified the correct insertion of H1 into the membrane. The truncated form (arrowheads) indicates the proteinase K-protected band. Right, efficiency of the translocation initiation of each segment. The glycosylated (b) and truncated (a) forms were quantified by image analysis, and the translocation initiation efficiency calculated using the equation ((a)/(b) x k) x 100, where k is the proteinase K protection efficiency of the translocated PL domain. Compensation was made for the number of methionines in each protected form.

 


View larger version (28K):
[in this window]
[in a new window]
 
FIG. 5.
The efficiency of the stop-transfer function of each segment. A, upper section, the model fusion protein used to test the stop-transfer function, consisting of the sequentially arranged signal peptide (S) of PL, a PL domain, the inserted segment of Kir 2.1 or KcsA, and a second PL domain. Lower section, if the inserted transmembrane region has stop-transfer function, the C-terminal portion remains on the cytoplasmic side and is digested by externally added proteinase K (ProK), but if it has no stop-transfer function, the molecule is fully translocated into the lumen and protected from digestion. B and C, left, autoradiographs of SDS-PAGE gels of the Kir 2.1 (B) and KcsA (C) constructs. Right, quantification of the stop-transfer data. The stop-transferred forms (a) and the fully translocated forms (b) were quantified by image analysis and compensation for the number of methionines in each protected band, and the stop-transfer efficiency calculated using the equation (a) x 100/((a) + (b)). D, summary of the topogenic function results for the individual segments of Kir 2.1 and KcsA obtained in this study and those for KAT1 obtained in a previous study (15).

 
The topogenic function of different regions of the 6 transmembrane segment-type voltage-dependent K+ channel has been examined recently (15, 16). In this case, the transmembrane segments of the voltage-sensing region, S3-S4, are simultaneously, rather than sequentially, integrated into the membrane via a newly recognized second type of membrane protein integration process, whereas segments S5, P, and S6 are integrated sequentially in a conventional manner (2-4). These results raised further questions on the membrane biogenesis of the pore-forming structure. Because the N-terminal end of S5 faces the cytoplasm, the orientation of S5 integration is predetermined as Ncyt/Cexo by the preceding segments, whereas in the two transmembrane segment-type K+ channels, M1 is the first transmembrane segment and must contain information for it to assume the correct Ncyt/Cexo orientation, but there is little information on this. Although the P region is highly hydrophobic, it never becomes transmembrane (5-7, 9, 11), and the folding process involved remains to be elucidated.

The arrangement of M1 and M2 is reported to differ between the bacterial K+ channel, KcsA, and the animal K+ channel, Kir 2.1. In KcsA, M1 and M2 interact intramolecularly, whereas in Kir 2.1, they interact both intra- and intermolecularly (17). Kir 2.1 forms a salt bridge between Glu and Arg in the P region, which is not present in KcsA or plant voltage-dependent K+ channels, and Kir 2.1 is therefore categorized as a structurally distinct class (17). It is not known whether these differences in the final membrane structure are due to differences in the topogenic functions of M1, the P region, and M2 in the two proteins. In ion transport proteins, the amino acid sequence forming the ion-conducting pathway is often surrounded by other segments of the polypeptide (18, 19). However, information on how the pore is formed and becomes embedded in the membrane is limited. In this study, we examined which topogenic features of M1, the P region, and M2 are shared by, or differ in, Kir 2.1 and KcsA and characterized the membrane biogenesis of K+ channels.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In Vitro Transcription, Translation, and Translocation—The constructs used for in vitro translation/translocation are shown in Figs. 2, 3, 4, 5, 6, 7, 8, 9. The DNAs encoding Kir 2.1 and KcsA were kind gifts from, respectively, Drs. Y. Kubo and L. Y. Jan (20) and Dr. R. MacKinnon (9). To assess the topogenic function of the individual segments, each PCR-amplified fragment was subcloned into the corresponding sites in the pCITE-2a-based plasmids used for topogenic assay (21). Fig. 1 shows the fragments, including the flanking cytoplasmic and extracellular sequences, used in the experiments shown in Figs. 2, 3, and 5. The cDNAs encoding wild-type prolactin (PL), PL containing an N-glycosylation site, or the type I signal-anchor sequence (SA-I) transmembrane region of the Escherichia coli leader peptidase (H1) were derived from plasmids described previously (21). In some constructs, the Kir 2.1 Trp81-Phe103 coding sequence was replaced with the coding sequence for Met1-Leu28 from mouse dipeptidyl peptidase IV (DPP IV), which is an SA-II transmembrane segment. All site-directed mutations were carried out using a two-step PCR approach (22). The RNAs were translated in the reticulocyte lysate system (21, 23) in the absence or presence of dog pancreas rough microsomal membranes (RM) (21, 24). Proteinase K was used for protease treatment; in all protease experiments, RM was checked for lack of leakage, which would affect the protease results, by testing the effect of addition of 0.5% Triton X-100 on the observed results. [35S]Methionine-labeled proteins were separated on SDS-PAGE gels, which were subjected to autoradiography.



View larger version (61K):
[in this window]
[in a new window]
 
FIG. 4.
N-terminal post-translational modification of Kir 2.1. A, the constructs coded for wild-type mature TNF ({Delta}pro-TNF), containing the sequence MVRSSSRTPS (no myristoylation or acetylation sites), mutants V2G, R3A-TNF, and V2G, R3D-TNF containing the indicated replacements, and Kir 2.1-TNF in which the first 10 amino acids were replaced by the N-terminal 10 amino acid residues of Kir 2.1. The mutant TNF proteins, V2G, R3A-TNF and V2G, R3D-TNF, were used to confirm the occurrence of N-myristoylation and N-acetylation, respectively (27). The N-myristoylation consensus motif, MGXXX(S/T)XX, and N-acetylation consensus motif, M(G/A/S/T), are shown boxed. B, detection of N-acetylation and N-myristoylation of the N terminus of Kir 2.1. The mRNAs were translated in vitro in the presence of [3H]leucine, [3H]myristic acid, or [3H]acetyl-CoA.

 


View larger version (42K):
[in this window]
[in a new window]
 
FIG. 6.
Exposure of the P region in Kir 2.1, KcsA, and KAT1 during membrane integration in the in vitro system and in COS-7 cells. A, constructs used to test exposure of the P region in the ER lumen. The N-terminal half of Kir 2.1, KcsA, or KAT1 was fused to a PL domain, and a novel N-glycosylation site generated by a single mutation in the P region (Q140N, A73N, or L258N in Kir 2.1, KcsA, or KAT1, respectively). B, glycosylation of the P region in the in vitro system. The efficiency of N-glycosylation, calculated as (intensity of glycosylated band)/(intensity of nonglycosylated band + intensity of glycosylated band), is shown on the right section of each panel. C and D, exposure of the P region of Kir 2.1 assessed using COS-7 cells. The C terminus of the entire Kir 2.1 molecule, with or without the Q140N mutation generating a glycosylation site in the P region, was fused to influenza virus hemagglutinin (HA) (C) and used to transfect COS-7 cells, then the products were examined by immunoblotting without treatment or after treatment with endoglycosidase H (EndoH) or peptide N-glycosidase F (PNG) (D). E, proposed model for the membrane topogenesis of the pore-forming region. The P region is exposed in the ER lumen before the channel achieves the final membrane topology. F, functional complementation assay of Kir 2.1 mutants using K+ uptake-deficient S. cerevisiae CY162. a, empty vector; b, wild-type Kir 2.1; c, Q140N Kir 2.1 mutant; d, Kir 2.1 with M1 replaced by Ncyt/Cexo-oriented hydrophobic transmembrane segment of DPP IV.

 


View larger version (18K):
[in this window]
[in a new window]
 
FIG. 7.
Contribution of M1 to the topogenesis and channel function of Kir 2.1. A, replacement of M1 in Kir 2.1 with the unrelated Ncyt/Cexo-oriented hydrophobic transmembrane segment of DPP IV. Met1-Leu28 of DPP VI was fused to Kir 2.1 containing M2 and the P region with or without Q140N. B, autoradiographs of SDS-PAGE gels of the Kir 2.1 constructs. The Q140N mutant was also tested for functional complementation in yeast, as shown in Fig. 6F.

 


View larger version (35K):
[in this window]
[in a new window]
 
FIG. 8.
Mutations in the P region in Kir 2.1. A-C, Thr at positions 139, 141, and 142 were replaced with Leu. The predicted secondary structures using the HNN, PHD, Predator, SIMPA96, and SOPM algorithms (pbil.univ-lyon1.fr/) are shown. h, {alpha}-helix. D and E, Glu at position 138 was replaced with Leu to disrupt the salt bridge between Glu138 and Arg148 in Kir 2.1 with Q148N.

 


View larger version (34K):
[in this window]
[in a new window]
 
FIG. 9.
Stabilization of M2 in KcsA by the C-terminal cytoplasmic region. A, constructs used to assess the contribution of the C-terminal cytoplasmic region of KcsA. The membrane topology of the P region and M2 in KcsA was tested using 8 constructs with or without A73N and with or without the C-terminal region fused to PL or PLgly. B, autoradiographs showing the effect of the C-terminal cytoplasmic region on the membrane integration of M2. The mono- and di-glycosylated forms are indicated by single and double dots, respectively. The arrowhead indicates the proteinase K-resistant band. Glycosylated and non-glycosylated sites are shown as filled and empty circles, respectively, in the schematic representation at the bottom.

 

Expression of Kir 2.1 in COS-7—cDNAs encoding full-length Kir 2.1 with or without the Q141N mutation were amplified by PCR with the HindIII site-containing primer, 5'-ATAAGCTTCCACCATGGGCAGTGTGAGAACCAAC-3', and the SpeI site-containing antisense primer, 5'-TTACTAGTTATCTCCGATTC-3'. The HindIII-SpeI-digested DNA was subcloned into the HindIII and XbaI sites of the pRcCMV-based plasmid constructed by Miyazaki et al. (25), and Kir 2.1 tagged C-terminally with influenza virus hemagglutinin (HA) was expressed from the resultant plasmid. Protein expression was performed essentially as described by Miyazaki et al. (25). COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum under a 10% CO2 atmosphere. Transfection was performed according to standard procedures using the FuGENE reagent (Roche Applied Science). After transfection, COS-7 cells in 3.5-cm culture dishes were cultured for 24 h and then lysed by sonication for 1 min in the denaturing buffer containing 0.5% SDS and 1% {beta}-mercaptoethanol. Where indicated, aliquots of the lysate were treated for 1 h at 37 °C with either endoglycosidase H (New England Biolabs) or peptide N-glycosidase F (New England Biolabs) using the conditions recommended by the supplier. The same amounts of protein were analyzed by SDS-PAGE and subsequent immunoblotting using a monoclonal anti-HA antibody (16B12, Covance, CA), bound antibody being detected using horseradish peroxidase-labeled anti-mouse IgG (BIOSOURCE) and ECL reagent (Amersham Biosciences).

Assay for N-Myristoylation and N-Acetylation of Kir 2.1—Plasmid pBDpro-TNF containing cDNA coding for the mature domain of TNF was constructed as described previously (26). Plasmids pBV2G,R3A-TNF and pBV2G,R3D-TNF (previously designated, respectively, as pBR3A-TNF and pBR3D-TNF) were constructed as described previously (27). Plasmid pBKir 2.1-TNF was constructed by PCR using pBDpro-TNF as template and the primers, 5'-ATATGGATCCATGGGCAGTGTGCGAACCAACCGCTACAGCGACAAGCCTGTAGCC-3' and 5'-GCCGGGATCCTAGGGCGAATTGGGTACC-3'. After digestion with BamHI and PstI, the amplified product was subcloned into pB at the BamHI and PstI sites. T3 polymerase was used to obtain transcripts of these cDNAs. The translation reaction was carried out using rabbit reticulocyte lysate (Promega) in the presence of [3H]leucine, [3H]myristic acid, or [3H]acetyl-CoA (Amersham Biosciences) using the conditions recommended by the manufacturer. The mixture (20 µl of rabbit reticulocyte lysate; 1 µl of 1 mM leucine-free amino acid mixture, or 1 mM complete amino acid mixture; 4 µl of [3H]leucine (5 µCi), [3H]myristic acid (25 µCi), or [3H]acetyl-CoA (2 µCi); and 4 µl of mRNA) was incubated for 90 min at 30 °C, and then the translation products were immunoprecipitated with polyclonal anti-hTNF antibody (R&D Systems) and protein G-Sepharose (Amersham Biosciences) and analyzed by SDS-PAGE and fluorography.

Yeast Complementation—To express the chimeric protein in yeast, cDNA encoding full-length Kir 2.1 was amplified by PCR using 5'-ATAAGCTTCCACCATGGGCAGTGTGAGAACCAAC-3'and 5'-TTGGATCCTCATATCTCCGATTCTCG-3', and the product was inserted into the pYES2-based vector used previously (22). The constructs were expressed under the control of the Gal1 promoter in the plasmid. Saccharomyces cerevisiae CY162, a gift from Dr. R. F. Gaber, was transformed as described previously (28). For complementation of S. cerevisiae CY162 with mutated Kir 2.1 (Q140N, or with M1 replaced with Met1-Leu28 of DPP IV), medium containing 6.7 g/liter of yeast nitrogen base (Difco), 2% galactose, 2% sucrose, 2% agar, and essential amino acids was used.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Assessment of Membrane Segments for Signal-Anchor Sequences—We used the animal and bacterial two-transmembrane K+ channels, Kir 2.1 and KcsA, to assess whether the same transmembrane segment in different K+ channels has the same membrane integration properties. The N-terminal cytosolic region in Kir 2.1 consists of about 78 amino acids (20), whereas that in KcsA consists of about 23 (9, 29) (Fig. 1). The topogenic function of the two transmembrane segments, M1 and M2, and the pore region, P, in Kir 2.1 and in KcsA was examined in the in vitro reticulocyte lysate protein synthesis system in the presence or absence of RM membranes. In the presence of RM, if the segment shows Nexo/Ccyt (SA-I) function, the N-terminal portion is translocated and glycosylated, whereas the PL remains outside the lumen and is susceptible to proteinase K digestion (Fig. 2A, left), and if it shows Ncyt/Cexo (SA-II) function, the PL is translocated and becomes proteinase K-resistant, and the N-terminal domain is not glycosylated (Fig. 2A, right). In the absence of RM, the model proteins were synthesized as single bands with the expected molecular masses (Fig. 2, B and C, lanes 1, 4, and 7). In the presence of RM, M1 of Kir 2.1 showed a glycosylated band (Fig. 2B, lane 2), indicating SA-I function, and a proteinase-protected band (Fig. 2B, lane 3), indicating SA-II function. The efficiency of SA-I and SA-II function was calculated using the equation described in the legend to Fig. 2B. For Kir 2.1 M1, the SA-I function was greater than the SA-II function, which is not appropriate for correct M1 insertion. We therefore postulated that the N-terminal cytoplasmic region up to M1 was crucial for the correct insertion of the M1 into the membrane and constructed a plasmid containing the sequence from the first methionine to Val118 which contains M1 (N-M1). By using this construct in the presence of RM, the intensity of the glycosylated band decreased (Fig. 2B, lane 11), and that of the proteinase-protected band increased (Fig. 2B, lane 12) compared with the corresponding bands with the M1 construct (Fig. 2B, lanes 2 and 3), showing that the N-terminal cytoplasmic region up to M1 contributes to the correct insertion of M1 into the membrane. In contrast, KcsA M1 possessed a strong SA-II function, leading to the correct final topology in the membrane (Fig. 2C).

The P region construct for either Kir 2.1 and KcsA did not give either glycosylated bands or proteinase K-resistant fragments (Fig. 2, B and C, lanes 4-6), showing that, although the P region is hydrophobic, it cannot integrate into the membrane on its own. This is consistent with the previously reported lack of topogenic function of the P region of the voltage-dependent K+ channel, KAT1 (15).

M2 in both Kir 2.1 and KcsA had SA-I function, as the constructs showed a glycosylated band (Fig. 2, B, lane 8, and C, lane 8). In addition, KcsA M2 showed a protease-protected band (Fig. 2C, lane 9), demonstrating that it possessed both SA-I and SA-II function.

Assessment of the Possibility of an Ncyt/Cexo Topology when the N-terminal of the Segment Is Located in the Cytoplasm—Although a transmembrane segment does not have SA-II function, it is possible that the segment initiates translocation when the N terminus of the segment faces the cytoplasm (21). We therefore evaluated the efficiency of the translocation initiation function of each transmembrane segment using the constructs shown in Fig. 3A; this function has been referred to as the internal SA-II function (21) or reinitiation function (15). For these experiments, the H1 segment of the E. coli leader peptidase (H1) was placed at the N terminus of M1; H1 acts as an SA-I transmembrane segment, and its function can be confirmed by the appearance of N-glycosylated bands (Fig. 3A) (21). If the inserted KcsA or Kir 2.1 transmembrane segment can integrate in the Ncyt/Cexo orientation, the C-terminal PL domain should become proteinase K-resistant (Fig. 3A, left). After proteinase K treatment, the constructs containing M1 of Kir 2.1 or M1 or M2 of KcsA gave substantial amounts of the truncated form (shown by an arrowhead; Fig. 3, B and C). These results show that, as long as the N-terminal end of M1 in Kir 2.1 or KcsA faced the cytoplasmic side, M1 could be correctly and effectively integrated into the membrane in the Ncyt/Cexo orientation. The translocation initiation function for each segment is shown in Fig. 3, B and C (right panels). M2 of Kir 2.1 showed low efficiency of membrane insertion, and the P region in both Kir 2.1 and KcsA did not show insertion.

Modification of the N-terminal Region of Kir 2.1—Post-translational modification of proteins assists in anchoring the protein in the membrane. The amino acid sequence of the N terminus of Kir 2.1 (MGSVRTNR) fits to the N-myristoylation consensus motif, MGXXX(S/T)XX (27, 30, 31). Protein N-myristoylation results from the cotranslational addition of myristic acid, a 14-carbon saturated fatty acid, to the Gly residue at the extreme N terminus after removal of the initiating Met by methionine aminopeptidase (32). The N-terminal sequence of Kir 2.1 also contains an N-acetylation consensus sequence, M(G/A/S/T) (32), which might be acetylated. Constructs coding for wild-type mature TNF ({Delta}pro-TNF), containing the sequence MVRSSSRTPS, mutants V2G, R3A-TNF, and V2G, R3D-TNF containing the indicated replacements site, and Kir2.1-TNF in which the first 10 amino acids were replaced by the N-terminal 10 amino acid residues of Kir 2.1 (Fig. 4A), were tested for their susceptibility to protein N-myristoylation and N-acetylation by metabolic labeling in an in vitro translation system (27). The mutant TNF proteins, V2G, R3A-TNF, and V2G, R3D-TNF, were used to confirm the occurrence of N-myristoylation and N-acetylation, respectively (27) (Fig. 4B). The Kir 2.1-TNF protein was acetylated but not myristoylated (Fig. 4B).

Assessment of the Stop-Transfer Function—The stop-transfer function interrupts ongoing translocation through the translocon. According to the "conventional insertion model" initially proposed by Blobel and co-workers (2-4), a stop-transfer function is essential for a transmembrane segment located after a Ncyt/Cexo-oriented transmembrane segment, such as M2. The stop-transfer function was examined as described previously (33) (Fig. 5A). The N-terminal signal peptide (S) on the fused protein initiates translocation, and then the following segment allows translocation into the membrane. If the inserted transmembrane segment shows stop-transfer function, the C-terminal half of the molecule (the second fused PL domain) is exposed on the cytoplasmic side of the membrane, and the domain is hydrolyzed by externally added proteinase K (Fig. 5A, left), and if the inserted transmembrane segment does not show stop-transfer function, the nascent polypeptide remains in the lumen space and is proteinase-resistant (Fig. 5A, right). Proteinase K treatment gave rise to truncated fragments of Kir 2.1 and KcsA (arrowheads; Fig. 5, B and C), indicating that M1 and M2 in both Kir 2.1 and KcsA showed a stop-transfer efficiency of almost 100% (Fig. 5, B and C). The P region did not have significant stop-transfer function and could not span the membrane.

The results for each segment of Kir 2.1 and KcsA in the present paper and for the voltage-dependent K+ channel, KAT1, (15) are summarized in Fig. 5D. KcsA M1 is probably able to integrate into the membrane without any support from the N-terminal cytoplasmic sequence. In contrast, the effective correct integration of the M1 in Kir 2.1, and the S5 in KAT1 is highly dependent on the localization of the preceding region. None of the three P regions have topogenic function. All M2/S6 have stop-transfer function to help stop their translocation and have SA-I and SA-II function with their different efficiency.

Exposure of the P Region on the Lumen Side of the ER during Membrane Integration—According to the crystal structure data for KcsA, MthK, KvAP, and KirBac 1.1 (5-7, 9), the P region exists as a loop in the membrane. During insertion into the membrane, the P region was thought to form the final structure inside the membrane space without ever being exposed in the lumen. To monitor the process of integration, we introduced potential N-glycosylation sites into the P region, because oligosaccharyltransferase can access polypeptide chains emerging from the translocon (34, 35). We generated an NXT sequence for N-glycosylation by a single amino acid substitution at the bottom of the loop in Kir 2.1 (substitution of Asn for Gln at position 140) and KcsA (substitution of Asn for Ala at position 73) (Fig. 6A). We also tested the P region of the plant Shaker-type K+ channel, KAT1, between S5 and S6 by mutating the corresponding position in the P region (Leu to Asn at position 258). All three constructs with glycosylation sites in the P region gave a glycosylated band in the presence of RM (Fig. 6B, lanes 5, 11, and 17), strongly suggesting that the P region was exposed on the lumen side of the ER during the membrane biogenesis process. We tested the effect of speed of peptide synthesis on integration of the P region into the membrane using the full-length Kir 2.1 (with and without Q140N mutation)-HA constructs shown in Fig. 6C and cultured COS-7 cells, in which synthesis and folding of membrane proteins proceed more rapidly than in the in vitro system (36). When expressed transiently in COS-7 cells, Kir 2.1-Q140N-HA, but not wild-type Kir 2.1-HA, showed a single glycosylated band, which was lost following treatment with endoglycosidase H or peptide N-glycosidase F (Fig. 6D). This shows that, as in the in vitro system, the P region was exposed on the lumen side of the ER before the protein arrived at the final membrane topology (Fig. 6E). Unexpectedly, the intensity of glycosylation was no less than in the in vitro system. It should be noted that, when the Q140N Kir 2.1 mutant was tested for functional complementation in yeast, it did not perform K+ uptake, presumably because the point mutation and/or the N-glycosylation disrupted K+ uptake activity (Fig. 6F).

By using the protease protection assay (Fig. 6B, lanes 3, 6, 15, and 18), M2 in Kir 2.1 and S6 in KAT1 were confirmed to take up the Nexo/Ccyt orientation in the membrane. With the KcsA constructs, although the isolated M2 showed strong stop-transfer function (Fig. 5), a protease-protected band was seen (Fig. 6B, lanes 9 and 12), suggesting that M2 in KcsA failed to completely stop its translocation. The contribution of the KcsA C-terminal region to membrane retention of M2 is examined below (Fig. 9).

The Influence of M1 on the Loop Structure of the P Region—We tested the role of M1 in the formation of the P region and K+ channel activity by replacement of M1 in Kir 2.1 with the unrelated Ncyt/Cexo-oriented hydrophobic transmembrane segment of DPP IV (Fig. 7A). Fig. 7B shows that the fusion bearing the Q140N replacement in the P region was glycosylated. The replacement of M1 did not affect the exposure of the P region in the ER lumen. The construct of wild-type Kir 2.1 in which M1 was replaced by the DPP IV peptide sequence did not confer K+ uptake activity in the yeast complementation assay (Fig. 6F).

Contribution of the Turn in the P Region to the Loop Structure—According to the x-ray crystal structure for KcsA, the hydrophobic P region is bent at the middle to form the loop (9). The amino acid sequence, TATT, constitutes the turn and is located at the C-terminal of the pore helix (8) (Fig. 1). The following random coil contains the K+-selective GYG signature sequence. We hypothesized that the turn helps to fold back the polypeptide in the P region. To examine this, we tried to extend the equivalent pore helix of Kir 2.1 (TQTT) by replacing all three Thr residues at positions 139, 141, and 142 with Leu, which has a high helical propensity (34) (Fig. 8A). Several secondary structure prediction methods (pbil.univ-lyon1.fr/) suggest that these replacements extend the {alpha}-helix (Fig. 8A); in addition, these replacements make the region more hydrophobic, as shown by the Kyte and Doolittle method (37) (data not shown). However, the N terminus-P region construct (Kir 2.1-M1-P-PL) showed a protease-protected band, indicating translocation of the P region into the ER lumen (Fig. 8, B and C, lane 3). By using Kir 2.1-M1-P-M2-PL containing the 3 Thr replacements, this band was not seen because of correct membrane insertion (Fig. 8C, lane 6). The mutations in the TQTT sequence therefore did not affect the exposure of the P region in the ER lumen.

Effect of the Salt Bridge between Glu138 and Arg148 on the Formation of the P Region—In Kir 2.1, Glu138 and Arg148 in the P region make a salt bridge (17). We tested the effect of this bridge on the correct topogenesis of the Kir 2.1-M1-P-PL construct by replacing Glu138 in the Q140N mutant with Leu and found that the Q140N glycosylated band was seen, and translocating PL was detected (Fig. 8, D and E). In Kir 2.1-M1-P-M2-PL containing the same replacements, this band was not seen. The disruption of the salt bridge therefore did not induce a significant change in the membrane biogenesis of the P region.

Contribution of the C-terminal Region to M2 Membrane Integration in KcsA—In Fig. 6B, lanes 9 and 12, translocation of M2 in KcsA was detected. We assumed that the cytoplasmic C-terminal region of KcsA stabilized the retention of M2 in the ER membrane. To test this, we introduced an N-glycosylation site into the C-terminal PL of KcsA-M1-2-PL and KcsA-M1-2-A73N-PL used in Fig. 6B and into the full-length wild-type and A73N mutant constructs (Fig. 9A). As shown in Fig. 9B, M1-2-PLgly showed a glycosylated band (lane 5), and M1-2-A73N-PLgly gave both single- and double-glycosylated bands (lane 11). The glycosylated bands indicate translocation of M2. However, by using full-length wild-type KcsA-PLgly, the intensity of the glycosylated band was less (lane 17), and by using full-length-A73N-PLgly, the double-glycosylated band was not seen (lane 23). In addition, both constructs gave a weaker protease-protected band (Fig. 9B, lanes 18 and 24). These results show that the C-terminal region can help M2 to span the membrane.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The membrane biogenesis of polytropic membrane intrinsic proteins has been studied recently, and membrane integration of transmembrane segments has been found to involve various types of topogenic function (19, 38, 39). The structure of K+ channel pore is well characterized, and the M1-P-M2 structure found in K+ channels is also seen in Na+ and Ca2+ channels and Na+/K+ transporters from bacteria and plants (10, 12, 13, 40). The pore-forming structure is therefore ubiquitous in cation transport proteins. There have been a few reports on K+ channel membrane biogenesis (15, 16, 41), but the membrane biogenesis of the structure is not yet well characterized. In this study, we analyzed a simple two-transmembrane segment-type K+ channel to address the membrane biogenesis of channels and transporters.

The M1 regions in Kir 2.1 and KcsA showed different topogenic function. M1 in KcsA possessed strong SA-II function, as would be expected for the first transmembrane region of a two-transmembrane region-type K+ channel. In contrast, M1 in Kir 2.1 had SA-II function but also had a stronger SA-I function, which led to the wrong orientation of insertion, and the cytoplasmic region preceding M1 helped in the correct Ncyt/Cexo orientation of M1 (Figs. 2C and 3). Interestingly, in the KAT1 channel, S5, which corresponds to M1, shows no SA-II function (15) (Fig. 5D). Because M1 is located further than M2 from the P region, forming the outer helix (5-7, 9), we tested whether M1 in Kir 2.1 could be replaced by other hydrophobic transmembrane domains by replacing it with another SA-II sequence from DDP IV unrelated to M1 (Fig. 7). The resultant chimeric protein showed the same membrane biogenesis of the P region as the wild-type protein, indicating that the topogenesis of the P region is not influenced by characteristics of amino acids in M1.

M2 is highly hydrophobic and forms the inner helix in the K+ channel (9). According to the previous study (15), S6 in KAT1 shows not only a stop-transfer function but also has a strong SA-I function (45%). Although we were unable to determine whether SA-I function is essential for S6, its SA-I function is likely to help the translocation of the P region into the lumen and the retention of S6 in the membrane. In contract, M2 in both Kir 2.1 and KcsA showed ~16% SA-I function, which is lower than that for S6 (Fig. 2, B and C). The weak SA-I function of M2 in KcsA may lead to the translocation of M2 seen in Fig. 6B, lanes 9 and 12, whereas the C-terminal cytoplasmic region helps to prevent M2 from translocating into the ER lumen (Fig. 9, A and B).

When we determined the topogenic function of the individual segments, the P region in Kir 2.1 and KcsA did not exhibit substantially any topogenic function (Fig. 5), a similar result to that previously observed for the KAT1 channel (15). The P region in K+ channels forms a loop consisting of a descending {alpha}-helix and an ascending stretch containing the selective filter (5-9). The crystallography data show a loop structure for the P region, which is possibly formed within the membrane. To test this, we monitored the location of the P region by creating a novel N-glycosylation site in the P region of Kir 2.1 by a small change in a side chain (Gln140 replaced by Asn), resulting in a potential glycosylated site at the bottom of the loop far from the ER lumen. This residue was strongly glycosylated both in the in vitro system and in COS-7 cells (Fig. 6D). The latter result was unexpected, as the rate of protein synthesis and the speed of folding of membrane proteins is greater in living cells than in the cell-free translation/translocation system (36), and we therefore expected to see less glycosylation. Similar N-glycosylation at the corresponding position has been reported in another two-transmembrane segment-type K+ channel, ROMK (42). This attachment of carbohydrate to the P region shows that the P region is exposed to the lumen space before the channel arrives at the final topology (Fig. 6E).

We also examined the structural determinants that support the membrane biogenesis of the pore-forming structure in Kir 2.1 channel. The turn between the pore helix and the GYG sequence (TATT in KcsA and TQTT in Kir 2.1) is probably responsible for the bend in the middle of the P region. We predicted that, if the turn were removed, the P region might become transmembrane, and we therefore replaced TQTT in Kir 2.1 with LQLL, as Leu tends to form a helix. This replacement was predicted by various secondary structure models to give a longer helix than the original pore helix (Fig. 8A). However, the P region containing LQLL was not transmembrane (Fig. 8C). This failed attempt at converting the P region from a loop to a transmembrane segment suggests that, despite its hydrophobic properties, the P region shows little propensity to take up a transmembrane configuration.

We analyzed the effect of the salt bridge in Kir 2.1 between Glu138 and Arg148 in the P region which is involved in the stabilization of the pore structure, as shown by Yang et al. (43), who demonstrated that the reversal double mutant channel, E138R/R148E, exhibits a significant decrease in current amplitude and was converted to a Na+-permeable K+ channel. According to the KcsA structure, Glu138 is located at the bottom of the P region and at the end of the pore helix. A single mutation at the corresponding position in KAT1 also induces a change in ion permeability (22, 44). When we converted Glu138 to a hydrophobic residue, Leu, in order to break the salt bridge (Fig. 8, D and E), the glycosylated band within the P region was still seen, and M2 was correctly inserted into the membrane. The salt bridge therefore does not act as a determinant for the topogenesis of the P region.

In this study, we found that the P region showed no topogenic function, despite its high hydrophobicity and a high prediction score for its being transmembrane and even though it is embedded in the membrane in the final structure. We can infer that the non-topogenic function of the P region in Kir 2.1, KcsA, and KAT1 is one of the determinants contributing to the final membrane structure of the K channel. The topogenic functions of M1 and M2 differed in Kir 2.1 and KcsA, and the cytoplasmic region was found to help in achieving the final membrane topology.


    FOOTNOTES
 
* This work was supported by a grant-in-aid for Center of Excellence Research (to N. U.), the 21st Century Center of Excellence Program (to N. U.), Grants-in-aid for Scientific Research 15013225, 15380070 (to N. U.), 14380294, 15013244 (to M. S.), and 15580080 (to T. U.) from the Ministry of Education, Science, Sports and Culture of Japan, grants from the Japan Society for the Promotion of Science Research of the Future Program (to N. U.), and the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ Present address: Dept. of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582, Japan. Back

{ddagger}{ddagger} To whom correspondence should be addressed: Bioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. Tel.: 81-52-789-5202; Fax: 81-52-789-5206; E-mail: uozumi{at}agr.nagoya-u.ac.jp.

1 The abbreviations used are: ER, endoplasmic reticulum; DPP, dipeptidyl peptidase; H1, H1 segment of the E. coli leader peptidase; PL, prolactin; RM, rough microsomal membrane; SA-I, type I signal-anchor sequence; SA-II, type II signal-anchor sequence; HA, hemagglutinin; TNF, tumor necrosis factor. Back


    ACKNOWLEDGMENTS
 
We thank to Drs. Y. Kubo and L. Y. Jan for providing DNAs encoding Kir 2.1 and Dr. R. MacKinnon for providing DNAs encoding KcsA.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Sakaguchi, M. (1997) Curr. Opin. Biotechnol. 8, 595-601[CrossRef][Medline] [Order article via Infotrieve]
  2. Blobel, G. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 1496-1500[Abstract/Free Full Text]
  3. Hegde, R. S., and Lingappa, V. R. (1997) Cell 91, 575-582[CrossRef][Medline] [Order article via Infotrieve]
  4. Matlack, K. E., Mothes, W., and Rapoport, T. A. (1998) Cell 92, 381-390[CrossRef][Medline] [Order article via Infotrieve]
  5. Jiang, Y., Lee, A., Chen, J., Ruta, V., Cadene, M., Chait, B. T., and MacKinnon, R. (2003) Nature 423, 33-41[CrossRef][Medline] [Order article via Infotrieve]
  6. Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B. T., and MacKinnon, R. (2002) Nature 417, 515-522[CrossRef][Medline] [Order article via Infotrieve]
  7. Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., and Doyle, D. A. (2003) Science 300, 1922-1926[Abstract/Free Full Text]
  8. Shindo, K., Takahashi, H., Shinozaki, K., Kami, K., Anzai, K., Lee, S., Aoyagi, H., Kirino, Y., and Shimada, I. (2001) Biochim. Biophys. Acta 1545, 153-159[CrossRef][Medline] [Order article via Infotrieve]
  9. Doyle, D. A., Morais Cabral, J., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69-77[Abstract/Free Full Text]
  10. Durell, S. R., and Guy, H. R. (1999) Biophys. J. 77, 789-807[Abstract/Free Full Text]
  11. Durell, S. R., Hao, Y., and Guy, H. R. (1998) J. Struct. Biol. 121, 263-284[CrossRef][Medline] [Order article via Infotrieve]
  12. Durell, S. R., Hao, Y., Nakamura, T., Bakker, E. P., and Guy, H. R. (1999) Biophys. J. 77, 775-788[Abstract/Free Full Text]
  13. Kato, Y., Sakaguchi, M., Mori, Y., Saito, K., Nakamura, T., Bakker, E. P., Sato, Y., Goshima, S., and Uozumi, N. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 6488-6493[Abstract/Free Full Text]
  14. Mäser, P., Hosoo, Y., Goshima, S., Horie, T., Eckelman, B., Yamada, K., Yoshida, K., Bakker, E. P., Shinmyo, A., Oiki, S., Schroeder, J. I., and Uozumi, N. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 6428-6433[Abstract/Free Full Text]
  15. Sato, Y., Sakaguchi, M., Goshima, S., Nakamura, T., and Uozumi, N. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 60-65[Abstract/Free Full Text]
  16. Sato, Y., Sakaguchi, M., Goshima, S., Nakamura, T., and Uozumi, N. (2003) J. Biol. Chem. 278, 13227-13234[Abstract/Free Full Text]
  17. Minor, D. L., Jr., Masseling, S. J., Jan, Y. N., and Jan, L. Y. (1999) Cell 96, 879-891[CrossRef][Medline] [Order article via Infotrieve]
  18. Kuma, H., Abe, Y., Askin, D., Bruce, L. J., Hamasaki, T., Tanner, M. J., and Hamasaki, N. (2002) Biochemistry 41, 3311-3320[CrossRef][Medline] [Order article via Infotrieve]
  19. Hamasaki, N., Abe, Y., and Tanner, M. J. (2002) Biochemistry 41, 3852-3854[CrossRef][Medline] [Order article via Infotrieve]
  20. Kubo, Y., Baldwin, T. J., Jan, Y. N., and Jan, L. Y. (1993) Nature 362, 127-133[CrossRef][Medline] [Order article via Infotrieve]
  21. Ota, K., Sakaguchi, M., Hamasaki, N., and Mihara, K. (1998) J. Biol. Chem. 273, 28286-28291[Abstract/Free Full Text]
  22. Uozumi, N., Gassmann, W., Cao, Y., and Schroeder, J. I. (1995) J. Biol. Chem. 270, 24276-24281[Abstract/Free Full Text]
  23. Jackson, R. J., and Hunt, T. (1983) Methods Enzymol. 96, 50-74[Medline] [Order article via Infotrieve]
  24. Walter, P., and Blobel, G. (1983) Methods Enzymol. 96, 84-93[Medline] [Order article via Infotrieve]
  25. Miyazaki, E., Sakaguchi, M., Wakabayashi, S., Shigekawa, M., and Mihara, K. (2001) J. Biol. Chem. 276, 49221-49227[Abstract/Free Full Text]
  26. Utsumi, T., Kuranami, J., Tou, E., Ide, A., Akimaru, K., Hung, M. C., and Klostergaard, J. (1996) Arch. Biochem. Biophys. 326, 179-184[CrossRef][Medline] [Order article via Infotrieve]
  27. Utsumi, T., Sato, M., Nakano, K., Takemura, D., Iwata, H., and Ishisaka, R. (2001) J. Biol. Chem. 276, 10505-10513[Abstract/Free Full Text]
  28. Anderson, J. A., Huprikar, S. S., Kochian, L. V., Lucas, W. J., and Gaber, R. F. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3736-3740[Abstract/Free Full Text]
  29. Schrempf, H., Schmidt, O., Kümmerlen, R., Hinnah, S., Müller, D., Betzler, M., Steinkamp, T., and Wagner, R. (1995) EMBO J. 14, 5170-5178[Medline] [Order article via Infotrieve]
  30. Boutin, J. A. (1997) Cell. Signal. 9, 15-35[Medline] [Order article via Infotrieve]
  31. Utsumi, T., Sakurai, N., Nakano, K., and Ishisaka, R. (2003) FEBS Lett. 539, 37-44[CrossRef][Medline] [Order article via Infotrieve]
  32. Bradshaw, R. A., Brickey, W. W., and Walker, K. W. (1998) Trends Biochem. Sci. 23, 263-267[CrossRef][Medline] [Order article via Infotrieve]
  33. Kuroiwa, T., Sakaguchi, M., Mihara, K., and Omura, T. (1991) J. Biol. Chem. 266, 9251-9255[Abstract/Free Full Text]
  34. Kida, Y., Sakaguchi, M., Fukuda, M., Mikoshiba, K., and Mihara, K. (2000) J. Cell Biol. 150, 719-729[Abstract/Free Full Text]
  35. Daniels, R., Kurowski, B., Johnson, A. E., and Hebert, D. N. (2003) Mol. Cell 11, 79-90[CrossRef][Medline] [Order article via Infotrieve]
  36. Kanki, T., Sakaguchi, M., Kitamura, A., Sato, T., Mihara, K., and Hamasaki, N. (2002) Biochemistry 41, 13973-13981[CrossRef][Medline] [Order article via Infotrieve]
  37. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132[CrossRef][Medline] [Order article via Infotrieve]
  38. Goder, V., Bieri, C., and Spiess, M. (1999) J. Cell Biol. 147, 257-266[Abstract/Free Full Text]
  39. Sakaguchi, M. (2002) Biochem. Biophys. Res. Commun. 296, 1-4[CrossRef][Medline] [Order article via Infotrieve]
  40. Durell, S. R., Bakker, E. P., and Guy, H. R. (2000) Biophys. J. 78, 188-199[Abstract/Free Full Text]
  41. Tu, L., Wang, J., Helm, A., Skach, W. R., and Deutsch, C. (2000) Biochemistry 39, 824-836[CrossRef][Medline] [Order article via Infotrieve]
  42. Schwalbe, R. A., Wang, Z., Bianchi, L., and Brown, A. M. (1996) J. Biol. Chem. 271, 24201-24206[Abstract/Free Full Text]
  43. Yang, J., Yu, M., Jan, Y. N., and Jan, L. Y. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1568-1572[Abstract/Free Full Text]
  44. Becker, D., Dreyer, I., Hoth, S., Reid, J. D., Busch, H., Lehnen, M., Palme, K., and Hedrich, R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8123-8128[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Zhang, Y. Sato, T. Hessa, G. von Heijne, J.-K. Lee, I. Kodama, M. Sakaguchi, and N. Uozumi
Contribution of hydrophobic and electrostatic interactions to the membrane integration of the Shaker K+ channel voltage sensor domain
PNAS, May 15, 2007; 104(20): 8263 - 8268.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C-W Lu, J-H Lin, Y S Rajawat, H Jerng, T G Rami, X Sanchez, G DeFreitas, B Carabello, F DeMayo, D L Kearney, et al.
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome
J. Med. Genet., August 1, 2006; 43(8): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
J. M. Cuthbertson, D. A. Doyle, and M. S.P. Sansom
Transmembrane helix prediction: a comparative evaluation and analysis
Protein Eng. Des. Sel., June 1, 2005; 18(6): 295 - 308.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bendahhou, M. R. Donaldson, N. M. Plaster, M. Tristani-Firouzi, Y.-H. Fu, and L. J. Ptacek
Defective Potassium Channel Kir2.1 Trafficking Underlies Andersen-Tawil Syndrome
J. Biol. Chem., December 19, 2003; 278(51): 51779 - 51785.
[Abstract] [Full Text] [PDF]


This Article